medgold resources corp (MED:Venture)
medgold resources corp (MED) Snapshot
|
Open
C$0.09
|
Previous Close
C$0.09
|
|
|
Day High
C$0.09
|
Day Low
C$0.09
|
|
|
52 Week High
12/19/12 - C$0.20
|
52 Week Low
05/7/13 - C$0.09
|
|
|
Market Cap
4.7M
|
Average Volume 10 Days
1.0K
|
|
|
EPS TTM
C$-0.01
|
Shares Outstanding
52.4M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
medgold resources corp (MED) Related Businessweek News
No Related Businessweek News Foundmedgold resources corp (MED) Details
Medgold Resources Corporation focuses on the discovery and development of gold and base metal deposits primarily in Italy, Spain, and Portugal. It has interests in the Pietratonda project that covers an area of eight square kilometers and is located to the northwest of Rome, Italy; and the Frassine project, which covers an area of eight square kilometers and is located in Tuscany, Italy. The company is headquartered in Vancouver, Canada.
medgold resources corp (MED) Key Developments
Medgold Resources Corp. has recently completed exploration at its wholly-owned Pietratonda licence in the Colline Metallifere of Central Italy. A total of 273 rock samples were collected (including QA-QC) and a Gold-Antimony anomaly was defined over 600 by 200 metres. The work outlines a large gold-antimony anomaly and highlights the exciting potential of the Colline Metallifere of Central Italy. Clear drill targets have been defined which are designed to test the mineralization at depth.
Medgold Resources Corp. announced that it has now completed the application process and paid all relevant taxes for three contiguous gold exploration permits covering 79 square kilometres in southern Galicia, Spain.
Medgold Resources Corp. announced that it has been issued the highly prospective 300 square kilometer Vila de Rei gold exploration licence in central Portugal. Licence located in highly prospective central Portuguese region; High-grade rock grab samples, from trace up to 24.7 g/t Au; Over 40 km of structure identified already; Exploration work to commence immediately over key prospect areas; Acquisition marks further step in Medgold's rapid expansion strategy. The licence was issued by the Direção-Geral de Energia e Geologia (DGEG) of Portugal, and was counter-signed by the Portuguese Minister of Economy and Employment, Álvaro Santos Pereira. It was presented to Medgold at the offices of the Ministry Economy and Employment in Lisbon by the Minister of the Economy and general directors of the DGEG. The Minister has recently publically commented that the Government is, and will continue, to ease legislation to fast-track strategic mineral resources into production. Furthermore, the Minister cites the mining sector as one of the most prospective growth industries, which will contribute to the Portuguese economy and help pull it from their financial crisis. The company is therefore very pleased to be working within a forward-thinking and mining-friendly jurisdiction. The Vila de Rei licence hosts shear-related gold mineralization in sediments. Several strike-extensive anomalies have been identified by previous explorers, with rock grab sampling yielding best results of 24.72, 22.85 and 19.24 g/t Au. Reconnaissance rock-chip sampling by Medgold yielded best results of 5.25 and 0.43 g/t Au from three samples. More recent reconnaissance work by Medgold has identified an intensely silicified zone within quartzites exposed intermittently over several hundred meters, with results pending. The sampling by previous companies is historical in nature, and reported in internal reports archived in the Laboratório Nacional de Energia e Geologia (LNEG) in Porto, Portugal, and have not been verified by Medgold, and are quoted for information purposes. Medgold's Qualified Person has verified that the technical information disclosed herein is an accurate summary of the internal reports. Ground crews are expected to commence licence-wide sampling and mapping, combined with detailed channel-chip sampling over the key prospects, in mid-April 2013. Initial detailed work will focus on the newly identified silicified zone in the central part of the licence.
| Recently Viewed | |||
| MED:CN | C$0.09 CAD | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for MED. | |||
| View Industry Companies | |||
Industry Analysis
MED
Industry Average
| Valuation | MED | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 8.1x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Owings Mills, MD | MedifastPosted: Apr 14
- Owings Mills, MD | Medifast CorporatePosted: May 16
- Dallas, TX | Medifast CorporatePosted: May 18
- Owings Mills, MD | Medifast CorporatePosted: May 16
Sponsored Financial Commentaries
Sponsored Links
To contact MEDGOLD RESOURCES CORP, please visit www.medgoldresources.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








